Ledger.Open graph →
SEC Form D · filed May 23, 2024

Eledon Pharmaceuticals, Inc

Offering
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

John Mcbride · Tampa, FLDirectorKeith Katkin · Irvine, CADirectorSteven Perrin · CAMBRIDGE, MAExec · DirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · DirectorJune Lee · Irvine, CADirectorAllan Kirk · RALEIGH, NCDirectorJohn Mcbride · Toronto, Ontario, CanadaDirectorJames Robinson · Vancouver, British Columbia, CanadaDirectorJan Hillson · Irvine, CADirectorPaul Little · Pine Ridge, SDExecBryan Smith · Richmond, TXExecWalter Ogier · Boston, MADirectorSteven Perrin · CAMBRIDGE, MAExec · DirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · DirectorJune Lee · Irvine, CADirectorAllan Kirk · RALEIGH, NCDirectorJohn Mcbride · Irvine, CADirectorJames Robinson · San Francisco, CADirectorKeith Katkin · Irvine, CADirectorJan Hillson · Irvine, CADirectorPaul Little · Irvine, CAExecBryan Smith · Kokomo, INExecWalter Ogier · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗